2008
DOI: 10.1111/j.1365-2044.2007.05411.x
|View full text |Cite
|
Sign up to set email alerts
|

Caesarean section in a complicated case of central core disease

Abstract: Summary We describe the anaesthetic management of a 21‐year‐old lady with central core disease for elective Caesarean section. Central core disease is characterised by muscle weakness, skeletal deformities and susceptibility to malignant hyperthermia. Total intravenous anaesthesia was used because of the combination of potential malignant hyperthermia, severe kyphoscoliosis and extensive spinal scarring. The authors believe there is no previous report of propofol and remifentanil being used in these circumstan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 23 publications
1
13
0
Order By: Relevance
“…The baby was initially apnoeic and required two doses naloxone at 3 and 5 min. His apgar scores were 3, 7, and 9 at 1, 5, 10 min respectively (15).…”
Section: Discussionmentioning
confidence: 93%
“…The baby was initially apnoeic and required two doses naloxone at 3 and 5 min. His apgar scores were 3, 7, and 9 at 1, 5, 10 min respectively (15).…”
Section: Discussionmentioning
confidence: 93%
“…The cause of MH may be associated with mutation of RYR1, a calcium release channel in the sarcoplasmic reticulum [23][24][25]. Central core disease may also be related to RYR1 mutation and is likely to be complicated with MH [26][27][28]. An RYR1 mutation has also been suggested to be involved in CNMDU1 [3].…”
Section: Discussionmentioning
confidence: 99%
“…Although the cause of this serious disease is unknown, involvement of ryanodine receptor gene mutation has been reported [16,17], and in light of reports on anesthesia in central core disease, which is a similar nonprogressive congenital muscular disease that is often complicated by ryanodine receptor gene mutation [18,19], we focused on preventing MH during anesthetic management.…”
Section: Discussionmentioning
confidence: 99%